Loading...
Loading...
Browse all stories on DeepNewz
VisitWhat will be the reported economic impact of Louisiana's vaccine policy change by end of 2025?
Less than $100M • 25%
$100M to $200M • 25%
$200M to $300M • 25%
More than $300M • 25%
Economic impact reports from Louisiana state government or independent economic analysis
Louisiana Bans Vaccine Promotion for COVID, Flu, and Mpox, Citing $100M-$300M Economic Impact
Dec 20, 2024, 05:48 PM
The Louisiana Department of Health has implemented a new policy that prohibits its public health workers from promoting vaccines for COVID-19, influenza, and mpox. According to NPR's investigation, this directive was communicated in meetings held in October and November 2024, with staff being instructed not to encourage the public to get these vaccines through any means, including press releases, interviews, events, presentations, or social media posts. The policy also prevents the department from displaying signs at its clinics indicating the availability of these vaccines. This shift in policy is part of a broader reevaluation of the state's public health priorities, moving away from what the department describes as 'one-size-fits-all paternalistic guidance' towards emphasizing individual choice in vaccination decisions. The change has raised concerns among health department employees about the potential impact on public health, with fears that it could lead to increased deaths from preventable diseases. The estimated annual economic impact on Louisiana due to lost productivity from flu alone is between $100M to $300M. This policy change follows the election of Gov. Jeff Landry, who has been critical of vaccine mandates.
View original story
Less than $1 million • 25%
$1 million to $5 million • 25%
$5 million to $10 million • 25%
More than $10 million • 25%
Increase in dismissals of similar lawsuits • 25%
No significant impact • 25%
Increase in settlements of similar lawsuits • 25%
Increase in filings of similar lawsuits • 25%
Less than $200 billion • 25%
$200 billion to $250 billion • 25%
$250 billion to $300 billion • 25%
More than $300 billion • 25%
Significant Surplus • 25%
Minor Surplus • 25%
Minor Deficit • 25%
Significant Deficit • 25%
Increase by more than 5% • 25%
Increase by 0-5% • 25%
No significant change • 25%
Decrease • 25%
0-3 Vaccines • 25%
4-7 Vaccines • 25%
8-11 Vaccines • 25%
12-14 Vaccines • 25%
Less than $1 million • 25%
$1 million to $5 million • 25%
$5 million to $10 million • 25%
More than $10 million • 25%
Less than $500 million • 25%
$500 million to $1 billion • 25%
$1 billion to $2 billion • 25%
More than $2 billion • 25%
Positive • 25%
Neutral • 25%
Negative • 25%
Mixed • 25%
Less than $100 million • 25%
$100 million to $500 million • 25%
$500 million to $1 billion • 25%
More than $1 billion • 25%
Stricter vaccine mandates • 25%
Looser vaccine mandates • 25%
No change • 25%
Other changes • 25%
Significant Improvement • 25%
Moderate Improvement • 25%
No Change • 25%
Deterioration • 25%
Yes • 50%
No • 50%
No • 50%
Yes • 50%
Economic impact concerns • 25%
Other reasons • 25%
Public health strategy shift • 25%
Political ideology • 25%